USD 3.0
(-0.13%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 2.93 Million USD | 10.0% |
2022 | 2.66 Million USD | 13.58% |
2021 | 2.34 Million USD | 12.94% |
2020 | 2.07 Million USD | 15.88% |
2019 | 1.79 Million USD | 4.74% |
2018 | 1.71 Million USD | 0.22% |
2017 | 1.7 Million USD | 10.22% |
2016 | 1.54 Million USD | 0.0% |
2002 | 7.85 Million USD | -43.74% |
2001 | 13.96 Million USD | 21.13% |
2000 | 11.52 Million USD | 11.27% |
1999 | 10.35 Million USD | 0.48% |
1998 | 10.31 Million USD | 17.57% |
1997 | 8.76 Million USD | -3.43% |
1996 | 9.08 Million USD | -18.93% |
1995 | 11.2 Million USD | 15.46% |
1994 | 9.7 Million USD | 7.78% |
1993 | 9 Million USD | 18.42% |
1992 | 7.6 Million USD | 22.58% |
1991 | 6.2 Million USD | 31.91% |
1990 | 4.7 Million USD | 683.33% |
1989 | 600 Thousand USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 689.92 Thousand USD | 13.07% |
2024 Q2 | 347.26 Thousand USD | -49.67% |
2023 Q1 | 815.01 Thousand USD | 27.4% |
2023 FY | 2.93 Million USD | 10.0% |
2023 Q4 | 610.19 Thousand USD | -16.56% |
2023 Q2 | 775.97 Thousand USD | -4.79% |
2023 Q3 | 731.25 Thousand USD | -5.76% |
2022 Q3 | 637.77 Thousand USD | -16.91% |
2022 Q1 | 636.15 Thousand USD | 43.3% |
2022 Q2 | 767.61 Thousand USD | 20.67% |
2022 FY | 2.66 Million USD | 13.58% |
2022 Q4 | 639.72 Thousand USD | 0.31% |
2021 FY | 2.34 Million USD | 12.94% |
2021 Q3 | 901.2 Thousand USD | 81.41% |
2021 Q2 | 496.77 Thousand USD | -1.47% |
2021 Q4 | 443.94 Thousand USD | -50.74% |
2021 Q1 | 504.16 Thousand USD | 0.0% |
2020 FY | 2.07 Million USD | 15.88% |
2019 FY | 1.79 Million USD | 4.74% |
2018 FY | 1.71 Million USD | 0.22% |
2017 FY | 1.7 Million USD | 10.22% |
2016 FY | 1.54 Million USD | 0.0% |
2003 Q1 | 1.79 Million USD | 4.78% |
2003 Q3 | 1.98 Million USD | 0.0% |
2003 Q2 | 1.98 Million USD | 10.34% |
2002 Q3 | 2.19 Million USD | 13.45% |
2002 Q2 | 1.93 Million USD | -3.97% |
2002 Q4 | 1.71 Million USD | -21.75% |
2002 FY | 7.85 Million USD | -43.74% |
2002 Q1 | 2.01 Million USD | -17.87% |
2001 FY | 13.96 Million USD | 21.13% |
2001 Q3 | 3.18 Million USD | -35.88% |
2001 Q2 | 4.96 Million USD | 47.56% |
2001 Q1 | 3.36 Million USD | 17.13% |
2001 Q4 | 2.45 Million USD | -23.0% |
2000 Q4 | 2.87 Million USD | 0.98% |
2000 Q3 | 2.84 Million USD | -2.13% |
2000 FY | 11.52 Million USD | 11.27% |
2000 Q2 | 2.9 Million USD | 0.83% |
2000 Q1 | 2.88 Million USD | 128.91% |
1999 Q3 | 3.1 Million USD | 3.33% |
1999 FY | 10.35 Million USD | 0.48% |
1999 Q2 | 3 Million USD | 0.0% |
1999 Q1 | 3 Million USD | 170.27% |
1999 Q4 | 1.25 Million USD | -59.39% |
1998 FY | 10.31 Million USD | 17.57% |
1998 Q1 | 2.7 Million USD | 178.64% |
1998 Q2 | 3.3 Million USD | 22.22% |
1998 Q3 | 3.1 Million USD | -6.06% |
1998 Q4 | 1.11 Million USD | -64.19% |
1997 Q4 | 969 Thousand USD | -61.24% |
1997 Q1 | 2.7 Million USD | 246.15% |
1997 FY | 8.76 Million USD | -3.43% |
1997 Q2 | 2.6 Million USD | -3.7% |
1997 Q3 | 2.5 Million USD | -3.85% |
1996 Q3 | 2.6 Million USD | -10.34% |
1996 Q4 | 780 Thousand USD | -70.0% |
1996 Q1 | 2.8 Million USD | -15.15% |
1996 FY | 9.08 Million USD | -18.93% |
1996 Q2 | 2.9 Million USD | 3.57% |
1995 Q4 | 3.3 Million USD | 26.92% |
1995 Q1 | 2.6 Million USD | 18.18% |
1995 Q2 | - USD | -100.0% |
1995 Q3 | 2.6 Million USD | 0.0% |
1995 FY | 11.2 Million USD | 15.46% |
1994 Q3 | 2.6 Million USD | 0.0% |
1994 Q4 | 2.2 Million USD | -15.38% |
1994 Q2 | - USD | -100.0% |
1994 Q1 | 2.4 Million USD | 4.35% |
1994 FY | 9.7 Million USD | 7.78% |
1993 Q1 | - USD | 100.0% |
1993 Q2 | 1.9 Million USD | 0.0% |
1993 Q3 | 2.3 Million USD | 21.05% |
1993 Q4 | 2.3 Million USD | 0.0% |
1993 FY | 9 Million USD | 18.42% |
1992 Q3 | - USD | 0.0% |
1992 Q1 | - USD | 100.0% |
1992 Q2 | - USD | 0.0% |
1992 FY | 7.6 Million USD | 22.58% |
1992 Q4 | -23.7 Million USD | 0.0% |
1991 FY | 6.2 Million USD | 31.91% |
1991 Q1 | - USD | 100.0% |
1991 Q2 | - USD | 0.0% |
1991 Q3 | - USD | 0.0% |
1991 Q4 | -20.4 Million USD | 0.0% |
1990 Q3 | - USD | 0.0% |
1990 Q4 | -14 Million USD | 0.0% |
1990 Q2 | - USD | 0.0% |
1990 Q1 | - USD | 100.0% |
1990 FY | 4.7 Million USD | 683.33% |
1989 Q1 | - USD | 0.0% |
1989 Q3 | - USD | 0.0% |
1989 Q4 | -10.5 Million USD | 0.0% |
1989 FY | 600 Thousand USD | 0.0% |
1989 Q2 | - USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
American Bio Medica Corporation | 1.04 Million USD | -179.431% |
Arrayit Corporation | 6.19 Million USD | 52.704% |
Atlantic International Corp. | 5.57 Million USD | 47.453% |
Biocept, Inc. | 29.4 Million USD | 90.03% |
Bioqual, Inc. | 7.44 Million USD | 60.648% |
CardioGenics Holdings Inc | 772.14 Thousand USD | -279.623% |
DermTech, Inc. | 104.01 Million USD | 97.182% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 98.24% |
HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 87.044% |
iMD Companies, Inc. | 151.8 Thousand USD | -1830.866% |
IDenta Corp. | 662.97 Thousand USD | -342.133% |
Interpace Biosciences, Inc. | 20.23 Million USD | 85.512% |
Integrative Health Technologies, Inc. | 38.88 Thousand USD | -7438.975% |
InVitro International | 661.32 Thousand USD | -343.236% |
Lumos Diagnostics Holdings Limited | 7.09 Million USD | 58.703% |
Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -4944.103% |
Medical Imaging Corp. | 1.91 Million USD | -53.294% |
NovelStem International Corp. | 3.53 Million USD | 17.145% |
Optigenex Inc. | 1.28 Million USD | -127.603% |
Proteome Sciences plc | 3.26 Million USD | 10.305% |
Response Genetics, Inc | 25.31 Million USD | 88.423% |
Rennova Health, Inc. | 7.67 Million USD | 61.822% |
RushNet, Inc. | 1.78 Million USD | -63.818% |
ScreenPro Security Inc. | 3.23 Million USD | 9.5% |
Stella Diagnostics Inc. | 11.42 Million USD | 74.348% |
StageZero Life Sciences Ltd. | 7.34 Million USD | 60.081% |
Todos Medical Ltd. | 14.05 Million USD | 79.149% |